|
|
|
Who we are |
|
|
|
|
|
|
- Dosage form: Oral Solids-Tablets
- Capacity: 240 million tablets/yr
- Approvals: WHO–GMP, UNICEF
- Corporate R & D center: for Formulations, APIs, Foods and Biotechnology
- Corporate Head Office: Materials Management, Marketing, Finance and International Business
- API Plant
- Capacity: 73000 kg/yr
- Approvals: WHO – GMP, US -FDA
- Dosage form: Oral Rehydration Salt Powder
- Capacity: 108 million ORS sachets/yr
- Approvals: WHO, UNICEF, UGANDA , MSF France
- World's Largest ORS manufacturing plant: delivers impeccable quality ORS in FFS Sachets
- Completely integrated lines: manufacturing, filling, sealing and packing
AURANGABAD (WALUJ), MAHARASHTRA |
- Dosage forms: Sterile Ophthalmic Preparations in BFS - LDPE vials offering 5ml, 10ml, 15ml and single dose vials (unims) in 0.5ml., Liquid Oral Solutions, Oral Rehydration Salt Powder, and External Powder preparations.
- Capacity:
- 38.4 million vials/yr (Sterile Ophthalmic)
- 9.6 million liquid oral bottles/yr
- 73.2 million ORS sachets/yr
- 3.6 million external powder containers/yr
- Approvals: WHO-GMP, MCC- South Africa, UK-MHRA, ANVISA Brazil, US-FDA, ISO 9001:2000, 13485:2003
- Unique Technology:
- BFS technology for ophthalmic preparations
- FFS technology for ORS preparations in sachets
- Integrated lines for manufacturing, filling, sealing and packing
VERNA, GOA (PLANTS I & II) |
- Goa I: Oral Solid Dosage - Tablets & Capsules
- Goa II: Oral Rehydration Salt Powder
- Capacity:
- 48 million capsules/yr
- 360 million tablets/yr
- 54 million ORS sachets/yr
- Approvals: WHO - GMP, UK-MHRA (Goa I), MCA (Zimbabwe), UNICEF
- Unique Technology:
- FFS technology for ORS Sachets
- Integrated lines for manufacturing, filling, sealing and packing
- Total manufacturing area under class 100000
- Dosage form: Tablets
- Capacity: 1200 million tablets/yr
- Designed to meet UK-MHRA and US-FDA requirements
- Salient attributes:
- Provision for ANDA batches
- High-speed and high-output manufacturing equipment and machines
- Total manufacturing area under class 100000
- Integrated lines for manufacturing, filling, sealing and packing
- Cephalosporin dosage forms: Tablets, Capsules and Oral Liquids
- Capacity:
- 480 million tablets/yr
- 14.4 million liquid oral bottles/yr
- 120 million capsules/yr
- Designed to meet: UK-MHRA and US-FDA regulatory requirements
- Salient attributes:
- Dedicated Plant for cephalosporin dosage forms
- Complete manufacturing area under class 100000
- Integrated lines for manufacturing, filling, sealing and packing to avoid mix ups
|
|
|
|
|
|
|
|
|
|